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Abstract
Introduction. Cardiac care continuum is an important factor affecting the treatment of patients after implantation of 
cardiac support devices. The aim of this paper was to assess the factors influencing compliance among 179 (67 women 
/ 112 men, aged 76.7 ± 8.6 years) randomly selected patients with implanted electrotherapy devices.
Material and methods. This was a retrospective and open study. Required data were obtained from patients’ medical 
history and questionnaires completed during follow-up visits and from patients’ medical records.
Results. It was shown that men were more likely to attend follow-up visits than women (p = 0.002), residents of large 
towns (over 100.000 population) more likely than residents of smaller towns (p = 0.02), patients under 65 years of age 
(p < 0.05) more likely than older patients and self-sufficient patients more likely than those needing others’ assistance 
(p < 0.05).
Patients living closer to the clinic (distance up to 50 km) and regularly taking medicines were not more compliant with 
their scheduled cardiology visits.
Conclusions. There are some factors associated with insufficient cooperation in the continuity of cardiac care in patients 
after implantation of cardiac support devices. Individual approach to patients who are non-compliant may be helpful in 
changing individual behaviors, which will result in treatment compliance.
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Introduction
The incidence of cardiovascular disease and the number 
of years of potential life lost due to the most common 
cardiac illnesses give priority to the prevention, diagnosis 
and treatment of diseases in this group [1]. In recent 
years, significant improvements have been observed in 
both the care funding and the availability of one of the 
cardiology fields — interventional cardiology[2]. There 
has been a marked improvement in the treatment of life 
threatening conditions. There has also been an increase 
in public awareness of cardiovascular diseases. Cardiac 
arrhythmias and congestive heart failure pose important 
cardiac complications. Knowledge of these serious medical 
conditions is still insufficiently distributed in the society [3] 
These diseases often require the use of medical procedu-
res, commonly referred to as electrophysiology, involving 
two areas of cardiology: implantation of cardiac implantable 
electronic devices and arrhythmia management.
The analysis of the articles of various authors [4-6] 
shows, that cardiovascular care is an important factor, 
which influences the correct course of treatment of cardiac 
arrhythmias, conduction disorders and heart failure in pa-
tients, who underwent implantation. Patients’ involvement 
in the treatment process and their following the medical 
advice, regarding frequent control visits, are complex 
problems that occur in every field of medicine.
Insufficient and ineffective patient cooperation in 
terms of adherence to medical advice is emphasised in 
many articles, but there is a total lack of the underlying 
cause of this phenomenon in the Polish literature.
Aim
The purpose of the study was to find out whether age, sex, 
comorbidity, patient’s residence (village/city), the degree 
of autonomy and continued medication were factors de-
termining the continuity of cardiac care in patients after 
implantation of cardiac implantable electronic devices.
Materials and Methods
The study was retrospective and open. The data were 
based on the medical history collected during an ongoing 
monitoring of 179 patients after implantation of cardiac 
implantable electronic devices in the Department of Cardio-
logy at Wroclaw Medical University Hospital and an analysis 
of the patients’ medical records. All the data were being 
collected within half-year period from 10.2014 to 03.2015 
and every patient, who agreed with the terms of this study, 
was included and then assigned to one of two groups — 
patients, who continued regular cardiac care, and patients 
who did not. The study also included medical records, which 
enabled the authors to evaluate the continuation of regular 
cardiac care over past two years. Cardiac care continuation 
meant, that patients did not skip more than one planned 
medical appointment, which, on average, took place every 
three months. The exact date of the visit could be chosen 
by the patient, but the choice of an outpatient clinic, as 
a place of visit, could not be changed. None of patients were 
analysed telemetrically. The age, sex, type of an implanted 
device, date of first implantation, indication for surgery, 
frequency of cardiac control, distance from home to clinic 
and the degree of patient autonomy were analysed. 
On 30 April 30 2015, the Bioethics Committee of the 
Medical University of Wroclaw received the approval of 
KB — 205/2015. The data were developed using Microsoft 
Office Excel. Statistical analysis was performed using Sta-
tistica 12 program, p <0.05 was considered statistically 
significant. In the statistical calculations, the Chi-square 
test and the t-Student test were used. The characteristics 
of the analysed patients group are presented in Table 1. 
Results
Characteristics of the analysed group of patients from the 
pacemaker out-patient clinic at Wroclaw Medical University 
Hospital are presented in Table 1.
Figure 1 shows the reasons for implantation of pacing 
devices. Sinus node disease and heart failure were the 
most common reasons for implantation of cardiac implan-
table electronic devices. Some patients had been diag-
nosed with more than one disease, included in Figure 1. 
For the needs of the analysis, it was determined that the 
patients regularity in continuing cardiac care may depend 
on the exact disease, therefore many cardiac conditions 
Table 1. Characteristic of the analysed group of patients from 
out-patient clinic in Clinical Hospital of Wroclaw Medical University
Number of patients n = 179 
Age [years ] mean 76,7
SD 8,6
Distance between 
patient’s house and 
Clinical Hospital 
[km]
mean distance 35
Wroclaw — city 54,2% (n=97)
up to 50 km 18,4% (n=33)
50–100 km 12,8% (n=23)
over 100 km 14,6% (n=26)
Place of residence city 82,1% (n=147) 
village 17,9% (n=32)
Degree of autonomy self-sufficient 38% (n=68)
coming to clinic 
with assistance
25,1% (n=45)
disabled 3,4% (n=6)
no information 33,7% (n=60)
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were detailed in the Figure. The authors emphasise, that 
the status after sudden cardiac arrest refers only to the 
patients who underwent ventricular fibrillation — ICD was 
implanted for secondary prevention of sudden cardiac de-
ath. The authors declare, that different groups of reasons 
for implantation in Figure 1 were depicted not to compare 
them with one another, but rather to specify the target 
group of patients. 
A pacemaker was the most often implanted device 
among all the patients — 106 patients had this device 
(59%). ICD (implantable cardioverter) and CRT (cardiac 
resynchronisation therapy) were implanted in 66 (37%) 
and 7 (4%) patients, respectively. Due to the fact, that the 
vast majority of patients had narrow QRS complex, there 
were no indications to implement CRT devices, despite 
significant number of patients with heart failure. ICD was 
implanted in many patients with heart failure as an indica-
tion due to narrow QRS complex and low ejection fraction.
Table 2 compares the frequency of regular cardiac care 
continuation between two main groups of patients divided 
always into two different groups in terms of factors such as 
age, sex and other. P value is given to indicate statistically 
significant differences among the chosen groups.
Male patients with implanted cardiac implantable 
electronic devices are significantly more likely to continue 
cardiac care than women (p= 0.002). City dwellers (in cities 
over 100 thousand people) are more likely to continue car-
diac care than residents of less populated areas (p = 0.02). 
Patients under 65 years old are more likely to continue 
cardiac care than the elderly above this age (70% vs. 
50%; p <0.05). Self-sufficient patients, referred to the out-
-patients clinic, were more likely to continue regular care 
than patients who needed assistance (62.7% vs 42,6%; 
p < 0.05). There was no correlation between the distan-
ce from the patient’s home to the clinical hospital and 
frequency of continuation regular cardiac care. Regular 
medication also did not have any influence on the conti-
nuation of cardiac care (p > 0,05) (Table 2).
Statistical analysis showed, that the mean age of pa-
tients continuing cardiac care is significantly lower than 
in the group of patients who did not continue cardiac care 
(Figure 2). Overall, in the whole analysed group of patients, 
only 55% of them continued regular cardiac care.
Statistical analysis (Figure 3) showed, that the mean 
period of time from the first implantation in the group of 
patients not continuing regular cardiac care was significan-
tly longer than in the group of patients continuing regular 
care (4,9 years vs. 8,1 years; p < 0,01).
Discussion
A review of the literature indicates, that this study is the first 
one which analyses the problem of follow-up after device 
implantation in Polish patients. Most of the published stu-
dies [6–8] refer to the assessment of control frequencies 
and changes in the parameters of implanted devices. This 
study emphasises the social and economic problems, which 
may hinder regular and recommended visits in the pace-
makers out-patient clinic at Wroclaw Medical University 
Hospital. Similar studies have been conducted in certain 
foreign centres [4–6, 12]. By analysing all the results, we 
can notice that only a small percentage of patients conti-
nued a proper follow-up after implantation of the pacing 
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Figure 1. Reasons of implantation of cardiac implantable elec-
tronic devices SSS — Sick Sinus Syndrome; AVB — Atrioventricular 
block; HF — Heart Failure
Table 2. Frequency of continuation regular cardiac care among patients with implanted electrotherapy device according to selected para-
meters
Frequency of continuation regular cardiac care among group of: p value
Patients in age below 65 years 67,5% Patients in age over 65 years 50,5% < 0,05
Males 65% Females 37,5% <0,05
Self-sufficient patients 62% Dependent patients 48,5% < 0,05
Patients taking medicaments continuously 52,5% Patients not taking medicaments continuously 52% > 0,05
Patients living in the city 57,5% Patients living in a village 29,5% <0,05
Patients having the distance to clinical hospital 
over 50 km
55% Patients having the distance to clinical hospital 
up to 50 km
45% > 0,05
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devices. In Hess et al. Study [4] less than half of the pa-
tients came for scheduled visits, while in our study, more 
than 50% of the patients continued regular visits. Similar 
results showed by Al-Khatib et al. [6], who analysed almost 
40.000 patients’ medical histories from the US base Me-
dicare, 50% of the patients came for scheduled first visit. 
Among those, who made a planned appointment, nearly 
70% were patients over 65 years old [4], however, among 
the presented group of patients, they were only 50%. It is 
worth emphasising that there was no correlation between 
the distance from the patient’s home to the pacemaker 
out-patient clinic at Wroclaw Medical University Hospital 
and adherence to recommendations, which would seem 
to be one of the most important difficulties in continuing 
regular cardiologists’ visits. There are no other results in 
the literature about the impact on the distance from the 
laboratory, which makes the reference to the other studies 
impossible. In this study, males significantly more often 
continue systematic visits. However, other authors did not 
notice any gender differences [6]. To highlight how impor-
tant systematic, planned follow-up visits of patients after 
implantation of devices for the stimulation of the heart are, 
it is worth to refer oneself to the study by Laksman et al. 
[5] with almost 9.000 patients after ICD implantation. The 
study showed an increased mortality among patients who 
did not come for the scheduled visit. Some other study, 
conducted by Hess’s team et al. [4], showed a lower total 
mortality among patients who came for regular follow-up 
visits to those who did not accomplished them within one 
year after implantation of the device. In several studies, due 
to the strategy of remote monitoring of cardiac implantable 
electronic devices, it has been possible to safely reduce the 
number of required follow-up visits [9-11]. Italian TARIFF 
study (Health Economics Evaluation Registry for Remote 
Follow-up) included 209 patients in two groups. Patients 
who were assigned to the first group came for the follow-
-up visits to the office every three months, while in the 
second group, examination in the third, sixth, ninth month 
was performed remotely. This resulted in more frequent 
actions in case of the second group to have been taken 
during in-person visits, which consequently affected the 
whole treatment. This also helped to reduce transportation 
costs, and more importantly, patients and accompanying 
people rarely left the workplace due to follow-up. It seems 
interesting to know, that in other studies, definitely more 
patients came with a companion 73% [12], 77% [11], 
compared with 28,5% in this study.
Conclusions
Our results suggest, that there are factors, which influence 
the continuity of cardiac care in patients after implantation 
of cardiac implantable electronic devices. 
Health centres might focus on the promotion of rou-
tine clinic follow-up among these particular groups to 
enhance the final compliance. Such approach could be 
helpful in changing individual behaviours and reducing 
the occurrence of noncompliant patients. 
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Figure 2. Mean age and standard differentiations of patients con-
tinuing and not continuing regular cardiac care
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Figure 3. The mean period of time from the first implantation of 
an electrotherapy device in patients continuing and not continuing 
regular cardiac care
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Streszczenie
Wstęp. Istotnym czynnikiem wpływającym na prawidłowy przebieg leczenia u pacjentów po implantacji urządzeń wspo-
magających pracę serca jest zachowanie ciągłości opieki kardiologicznej. Celem pracy była ocena czynników wpływa-
jących na przestrzeganie zaleceń u 179 (67 kobiet/112 mężczyzn; wiek 76,7 ± 8,6 lat) wybranych losowo pacjentów 
z implantowanymi urządzeniami do elektroterapii.
Materiał i metody. Badanie miało charakter retrospektywny i otwarty. Dane uzyskano na podstawie wywiadu lekarskiego 
i ankiet zebranych podczas bieżących kontroli pacjentów oraz analizę dokumentacji medycznej.
Wyniki. Wykazano, że istotnie częściej do kontroli kardiologicznej zgłaszali się mężczyźni niż kobiety (p = 0,002), miesz-
kańcy większych miast (powyżej 100 000 ludności) w porównaniu z mieszkańcami mniejszych miejscowości (p = 0,02), 
chorzy poniżej 65 roku życia (p < 0,05) oraz pacjenci samodzielni (p < 0,05).
Nie stwierdzono, aby pacjenci mieszkający bliżej poradni (odległość do 50 km) oraz regularnie przyjmujący leki istotnie 
częściej korzystali z opieki kardiologicznej.
Wnioski. Istnieją pewne czynniki wpływające na niedostateczną współpracę w zakresie ciągłości opieki kardiologicznej 
u pacjentów po implantacji urządzeń wspomagających pracę serca. Indywidualne podejście do pacjentów niespełnia-
jących zaleceń lekarskich może być pomocne w zmianie indywidualnych zachowań, co wpłynie na prawidłowy przebieg 
leczenia.
Słowa kluczowe: elektroterapia serca, elektrofizjologia, urządzenie stymulujące pracę serca, regularność wizyt,  
przestrzeganie zaleceń lekarskich
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